Accepted for publication 26 November 1980 Material and methods Paraffin-embedded blocks of human tissues which had been fixed in either formol saline or neutral buffered formalin and stored for up to four years, were obtained from the files of the pathology departments in Aberdeen and Glasgow. The EPA antiserum (provided by Professor Tatarinov) was raised in rabbits using semi-purified EPA preparations and rendered monospecific by subsequent absorption using pooled human plasma and extract of normal tissues.
Human embryonic prealbumin (EPA) is a recently described fetal protein which has been shown to be non-identical with a variety of oncofetal antigens, including alphafetoprotein, carcinoembryonic antigen, pregnancy-specific glycoprotein and betaoncofetal antigen.1 It is a glycoprotein containing 21 % carbohydrate and there are two immunologically identical forms of the protein, one having a molecular weight of 41 000, the other 68 000. With an immunodiffusion technique, EPA is detectable in normal fetal serum at an early stage of development, the serum concentration rising steadily and reaching a peak between the 20th and 30th week of gestation. Immunodiffusion studies have also demonstrated that it is present in homogenates of tumours, especially those of connective tissue origin, and in over 17 different fetal adult fibroblast cell lines. [2] [3] [4] With the fluorescent antibody technique Kalashnikov and his colleagues3 have shown it can be localised within placenta, umbilical cord, fetal tissues (including skin, bone, and kidney) and in the stroma surrounding some epithelial tumours. In our study, using an indirect immunoperoxidase technique, we have examined formalin-fixed paraffin embedded human fetal and adult tissues for the presence and distribution of EPA, including benign and malignant tumours. In addition, to determine whether or not EPA is truly an oncofetal protein, tissues and organs from patients with various nonneoplastic conditions were studied.
Accepted for publication 26 November 1980 Material and methods Paraffin-embedded blocks of human tissues which had been fixed in either formol saline or neutral buffered formalin and stored for up to four years, were obtained from the files of the pathology departments in Aberdeen and Glasgow. The EPA antiserum (provided by Professor Tatarinov) was raised in rabbits using semi-purified EPA preparations and rendered monospecific by subsequent absorption using pooled human plasma and extract of normal tissues.
IMMUNOPEROXIDASE TECHNIQUE
The immunoperoxidase techniques used in both departments were essentially the same except that the addition of trypsin before the addition of the normal swine serum was not carried out by the Glasgow department. Despite this there did not appear to be any qualitative difference in the preparations from the two departments.
Sections (5 ,tm) Endothelial cells within the tumours also contain EPA and this is well illustrated by the striking perivascular deposition of EPA in glioblastoma multiforme (Fig. 2) .
Screening of fetal tissues shows that EPA is detectable in the mesenchymal cells of umbilical cord, fibroblasts especially of the upper dermis, cartilage and in the distal renal tubular epithelium (Fig. 3) . "Normal" adult (male and female) tissues That EPA is not simply a product of neoplastic cells is shown by its frequent presence in a variety of non-neoplastic conditions (Table 3 ). This also shows the precise distribution of EPA in such tissues. EPA is frequently detectable in adult kidneys (Table 3) . Apart from its presence in distal tubular epithelial cells periglomerular deposition of EPA is a notable feature in some adult kidneys (Fig. 4) Immunoperoxidaselmethyl green x 650.
cancers, whereas in 10 such cancers we did not find any which stained positively for EPA; indeed the vast majority of all malignant epithelial tumours studied do not appear to produce EPA. At present there is no obvious explanation for the difference between Tatarinov's findings4 in respect of breast cancer and our own.
The most important aspect of our study was the detection of EPA in a variety of non-neoplastic tissues. While it is perhaps not surprising to find EPA in fibroblasts in granulation tissue, which are rapidly dividing cells of mesodermal origin, and also in irradiated fibroblasts, we did not anticipate finding EPA in renal tubular epithelial cells in patients who did not have tumours. This is thought to be a result of reabsorption rather than synthesis in the kidney itself. The apparent high frequency of occurrence suggests that the appearance of EPA in the circula- 
